Literature DB >> 20971189

Correlation between in vitro and in vivo erosion behaviour of erodible tablets using gamma scintigraphy.

Manish Ghimire1, Lee Ann Hodges, Janet Band, Blythe Lindsay, Bridget O'Mahony, Fiona J McInnes, Alexander B Mullen, Howard N E Stevens.   

Abstract

In vitro and in vivo erosion behaviour of erodible tablets consisting of glyceryl behenate and low-substituted hydroxypropylcellulose manufactured using three different methods: direct compression (DC), melt granulation (MG) and direct solidification (DS) was investigated. In vitro erosion behaviour was studied using gravimetric and scintigraphic methods. For scintigraphic investigations, the radiolabel was adsorbed onto activated charcoal and incorporated into tablets at a concentration that did not affect the erosion profile. A clinical study was carried out in six healthy volunteers using gamma scintigraphy. Tablet erosion was affected by the preparation method and was found to decrease in the order of preparation method, DC>MG>DS tablets. The mean in vivo onset time for all tablets (DC: 6.7±3.8 min, MG: 18.3±8.1 min, DS: 67±18.9 min) did not differ significantly from in vitro onset time (DC: 5.3±1 min, MG: 16.8±3.9 min, DS: 61.8±4.7 min). The mean in vivo completion times were found to be 36.6±9.7 (DC tablets), 70±18.3 min (MG tablets) and 192.5±39.9 min (DS tablets). Among the three different erodible tablets, MG tablets showed the highest correlation between in vitro and in vivo mean erosion profile and suggested a potential platform to deliver controlled release of water-insoluble compounds.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971189     DOI: 10.1016/j.ejpb.2010.10.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Optimization of LY545694 tosylate controlled release tablets through pharmacoscintigraphy.

Authors:  Evelyn D Lobo; Mark D Argentine; David C Sperry; Alyson Connor; John McDermott; Lloyd Stevens; Ahmad Almaya
Journal:  Pharm Res       Date:  2012-06-14       Impact factor: 4.200

2.  Pharmacokinetics of ketorolac tromethamine compression-coated tablets for colon delivery.

Authors:  Sateesh Kumar Vemula; Prabhakar Reddy Veerareddy; Venkat Ratnam Devadasu
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

3.  Pharmacokinetics of colon-specific pH and time-dependent flurbiprofen tablets.

Authors:  Sateesh Kumar Vemula; Prabhakar Reddy Veerareddy; Venkat Ratnam Devadasu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-06-11       Impact factor: 2.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.